Instruments
Chemometec designs and sells NucleoCounter instruments that count and analyze cells in a lab sample. The machines are used in life science labs, biotech companies, and drug makers that need to measure cells for research...
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Chemometec A/S makes laboratory instruments and consumables used to count, analyze, and prepare cells. Its core products are automated cell counters and related reagents that help scientists measure how many cells they have, how healthy they are, and whether they are ready for further testing or production.
Its customers are mainly pharmaceutical and biotech companies, research labs, and manufacturers working with cell-based medicines and biological testing. Chemometec earns money by selling the instruments themselves and, just as importantly, by supplying the single-use reagents and consumables that the instruments need to run.
That mix gives the business a recurring revenue model: a customer may buy the machine once, but then keeps purchasing the consumables over time. The company sits in a specialized part of the life-science tools market, where accuracy, ease of use, and consistency matter more than low price.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more